Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2—Tumor and Immunological Responses-Reference-Cited by-同舟云学术

Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2—Tumor and Immunological Responses

Published:2012-06-06 Issue:137 Volume:4 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Seung Steven K.¹²,Curti Brendan D.¹³,Crittenden Marka¹²,Walker Edwin¹,Coffey Todd³,Siebert Janet C.⁴,Miller William¹,Payne Roxanne³,Glenn Lyn³,Bageac Alexandru⁵,Urba Walter J.¹³

Affiliation:

1. Earle A. Chiles Research Institute, Portland, OR 97213, USA.

2. The Oregon Clinic, Portland, OR 97213, USA.

3. Providence Cancer Center, Portland, OR 97213, USA.

4. CytoAnalytics, Denver, CO 80217, USA.

5. Providence Portland Medical Center, Portland, OR 97213, USA.

Abstract

Stereotactic body radiation therapy enhances tumor response rate to high-dose interleukin-2 in a phase 1 study.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference36 articles.

1. Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

2. High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993

3. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

4. Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

5. Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Cited by 278 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multifunctional targeted nano-delivery system with radiosensitization and immune activation in glioblastoma;Radiation Oncology;2024-09-12

2. Novel engineered IL-2 Nemvaleukin alfa combined with PD1 checkpoint blockade enhances the systemic anti-tumor responses of radiation therapy;Journal of Experimental & Clinical Cancer Research;2024-09-02

3. Tumor-Localized Interleukin-2 and Interleukin-12 Combine with Radiation Therapy to Safely Potentiate Regression of Advanced Malignant Melanoma in Pet Dogs;Clinical Cancer Research;2024-07-09

4. Radiotherapy enhances efficacy of PD-1 inhibitors in advanced hepatocellular carcinoma: A propensity-matched real-world study;Chinese Medical Journal;2024-05-09

5. Immunotherapy and Radiotherapy Combinations for Sarcoma;Seminars in Radiation Oncology;2024-04